Albemarle Corporation (ALB) Price Target Raised to $155.00

Albemarle Corporation (NYSE:ALB) had its target price boosted by Royal Bank Of Canada from $149.00 to $155.00 in a research report released on Friday, Marketbeat Ratings reports. Royal Bank Of Canada currently has an outperform rating on the specialty chemicals company’s stock.

A number of other equities research analysts have also recently weighed in on the stock. UBS AG lifted their price target on shares of Albemarle Corporation from $123.00 to $150.00 and gave the company a neutral rating in a research report on Thursday, November 9th. Robert W. Baird reiterated a hold rating and set a $135.00 price target on shares of Albemarle Corporation in a research report on Wednesday, November 1st. BMO Capital Markets started coverage on shares of Albemarle Corporation in a research report on Tuesday, October 24th. They set an outperform rating and a $160.00 price target for the company. Jefferies Group LLC reissued a buy rating on shares of Albemarle Corporation in a research note on Tuesday, October 24th. Finally, Zacks Investment Research raised shares of Albemarle Corporation from a hold rating to a buy rating and set a $157.00 price objective for the company in a research note on Tuesday, October 17th. Eight analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $128.15.

Shares of Albemarle Corporation (ALB) opened at $143.37 on Friday. Albemarle Corporation has a 12-month low of $76.32 and a 12-month high of $144.99. The stock has a market cap of $15,840.00, a PE ratio of 34.81, a P/E/G ratio of 2.14 and a beta of 1.72. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.56 and a current ratio of 2.11.

Albemarle Corporation (NYSE:ALB) last released its quarterly earnings data on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.01. Albemarle Corporation had a net margin of 30.07% and a return on equity of 11.61%. The firm had revenue of $755.00 million during the quarter, compared to analysts’ expectations of $732.19 million. During the same period last year, the business earned $0.91 earnings per share. Albemarle Corporation’s revenue was up 15.4% compared to the same quarter last year. analysts predict that Albemarle Corporation will post 4.45 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.thestockobserver.com/2017/11/14/albemarle-corporation-alb-price-target-raised-to-155-00.html.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a yield of 0.89%. Albemarle Corporation’s dividend payout ratio is currently 45.71%.

In other Albemarle Corporation news, EVP Matthew Juneau sold 5,397 shares of the firm’s stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $115.77, for a total transaction of $624,810.69. Following the sale, the executive vice president now owns 360 shares of the company’s stock, valued at $41,677.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Karen G. Narwold sold 11,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the sale, the executive vice president now directly owns 36,620 shares in the company, valued at approximately $4,246,089. The disclosure for this sale can be found here. 0.74% of the stock is owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Albemarle Corporation by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,501,329 shares of the specialty chemicals company’s stock worth $1,319,389,000 after purchasing an additional 213,530 shares in the last quarter. Jennison Associates LLC raised its holdings in Albemarle Corporation by 21.4% during the third quarter. Jennison Associates LLC now owns 7,797,076 shares of the specialty chemicals company’s stock worth $1,062,819,000 after purchasing an additional 1,375,546 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Albemarle Corporation by 258.1% during the third quarter. Bank of New York Mellon Corp now owns 4,561,987 shares of the specialty chemicals company’s stock worth $621,845,000 after purchasing an additional 3,287,989 shares in the last quarter. TIAA CREF Investment Management LLC raised its holdings in Albemarle Corporation by 69.2% during the second quarter. TIAA CREF Investment Management LLC now owns 1,661,821 shares of the specialty chemicals company’s stock worth $175,389,000 after purchasing an additional 679,453 shares in the last quarter. Finally, Allianz Asset Management GmbH raised its holdings in Albemarle Corporation by 98.8% during the third quarter. Allianz Asset Management GmbH now owns 1,307,904 shares of the specialty chemicals company’s stock worth $178,281,000 after purchasing an additional 650,158 shares in the last quarter. 86.64% of the stock is currently owned by institutional investors.

Albemarle Corporation Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Analyst Recommendations for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply